Since donepezil is the most commonly prescribed medication for AD [4], and several other studies have focused on this drug to generate multifunctional compounds targeting various hallmarks of AD, including BACE1 [16,17,18,19], we decided to generate multi-targeted analogues derived from donepezil that would inhibit ChEs and β-secretase. This evidence concerns the gene BACE1 and Alzheimer disease.